Literature DB >> 23072549

Rehabilitative orbital decompression for Graves' orbitopathy: risk factors influencing the new onset of diplopia in primary gaze, outcome, and patients' satisfaction.

Roberto Rocchi1, Riccardo Lenzi, Michele Marinò, Francesco Latrofa, Marco Nardi, Paolo Piaggi, Barbara Mazzi, Maria Antonietta Altea, Aldo Pinchera, Paolo Vitti, Claudio Marcocci, Stefano Sellari-Franceschini.   

Abstract

BACKGROUND: Patients with moderate to severe Graves' orbitopathy (GO) rather frequently require rehabilitative surgery after medical therapy. Diplopia is the most common side effect of orbital decompression (OD). The aim of this study was to evaluate the occurrence of postoperative diplopia in primary gaze after OD, and the influence of the surgical approach on this outcome. Moreover, we investigated the results in terms of proptosis reduction, and the long-term subjective satisfaction of patients treated with OD with regard to their appearance and ocular function.
METHODS: A retrospective evaluation of 247 patients with GO treated with medial and lateral decompression (MLD) or lateral decompression (LD) OD between January 2002 and December 2009 was performed.
RESULTS: The overall prevalence of postoperative diplopia in primary gaze was 55/247 (22.3%), with a statistically significant difference (p<0.001) between patients with (36/113, 31.2%) and those without (19/134, 14.2%) preoperative diplopia in secondary gaze. The surgical procedure influenced the outcome in patients without preoperative diplopia (17.8% after MLD and 0% after LD, p=0.02), but not in patients with preoperative diplopia in secondary gaze (33.3% after MLD and 26.1% after LD, p=0.5). Overall, proptosis reduction was 5.7±2.2 mm (1-11 mm), after MLD and 4.0±1.6 mm (1-8 mm) after LD (p<0.001). Fifty-one out of 55 patients with constant, postoperative diplopia in primary gaze after OD underwent squint surgery, which was successful in all but two. Four patients refused squint surgery. Patients were also interviewed for satisfaction in terms of recovery of their appearance and ocular function after a mean of 6 years from surgery (range 2-9 years): more than 85% of patients reported a good to excellent postoperative satisfaction for both items.
CONCLUSIONS: Preoperative diplopia in secondary gaze is a risk factor for the development of diplopia in primary gaze after OD, independently of the surgical approach (MLD vs. LD). In absence of diplopia, MLD, but not LD, seems to be associated with its development in primary gaze. The reduction in proptosis after MLD is greater than that after LD. Most patients were satisfied with the results of both appearance and ocular function after OD.

Entities:  

Mesh:

Year:  2012        PMID: 23072549     DOI: 10.1089/thy.2012.0272

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  14 in total

Review 1.  Orbital wall decompression in the management of Graves' orbitopathy: a systematic review with meta-analysis.

Authors:  Federico Maria Gioacchini; Shaniko Kaleci; Ettore Cassandro; Alfonso Scarpa; Michele Tulli; Claudia Cassandro; Massimo Ralli; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-18       Impact factor: 2.503

Review 2.  Iatrogenic diplopia [corrected].

Authors:  Julio González-Martín-Moro; Julio José González-López; Marco Sales-Sanz; Andrea Sales-Sanz; Javier González-Martín-Moro; Fernando Gómez-Sanz; Mar González-Manrique; Belén Pilo-de-la-Fuente; Roberto García-Leal
Journal:  Int Ophthalmol       Date:  2014-03-07       Impact factor: 2.031

3.  [Orbital decompression : Indications, technique, results].

Authors:  H-J Welkoborsky; S K Graß; J Küstermeyer; K V Steinke
Journal:  HNO       Date:  2017-12       Impact factor: 1.284

4.  Natural history of graves' orbitopathy after treatment.

Authors:  Francesca Menconi; Marenza Leo; Elena Sabini; Teresa Mautone; Marco Nardi; Aldo Sainato; Stefano Sellari-Franceschini; Paolo Vitti; Claudio Marcocci; Michele Marinò
Journal:  Endocrine       Date:  2016-10-05       Impact factor: 3.633

5.  The effect of intravenous high-dose glucocorticoids and orbital decompression surgery on sight-threatening thyroid-associated ophthalmopathy.

Authors:  Yun Wen; Jian-Hua Yan
Journal:  Int J Ophthalmol       Date:  2019-11-18       Impact factor: 1.779

6.  Rehabilitative orbital decompression for Graves' orbitopathy: results of a randomized clinical trial.

Authors:  S Sellari-Franceschini; R Rocchi; M Marinò; A Bajraktari; B Mazzi; G Fiacchini; P Lepri; I Dallan; P Vitti; C Marcocci
Journal:  J Endocrinol Invest       Date:  2018-02-15       Impact factor: 4.256

Review 7.  Orbital decompression for thyroid eye disease: methods, outcomes, and complications.

Authors:  J M Jefferis; R K Jones; Z I Currie; J H Tan; S M Salvi
Journal:  Eye (Lond)       Date:  2017-12-15       Impact factor: 3.775

Review 8.  Critical Appraisal on Orbital Decompression for Thyroid Eye Disease: A Systematic Review and Literature Search.

Authors:  Konstadinos G Boboridis; Jimmy Uddin; Dimitrios G Mikropoulos; Catey Bunce; George Mangouritsas; Irini C Voudouragkaki; Anastasios G P Konstas
Journal:  Adv Ther       Date:  2015-07-23       Impact factor: 3.845

9.  Orbital decompression in the system of treatment for complicated thyroid eye disease: case report and literature review.

Authors:  Dilyara S Ismailova; Irina M Belovalova; Yaroslav O Grusha; Natalya Y Sviridenko
Journal:  Int Med Case Rep J       Date:  2018-10-01

10.  Results after En Bloc Lateral Wall Decompression Surgery with Orbital Fat Resection in 111 Patients with Graves' Orbitopathy.

Authors:  Nicole Fichter; Rudolf F Guthoff
Journal:  Int J Endocrinol       Date:  2015-06-28       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.